Search research articles
Contact Us
Filters
Showing results (41-50 of 61) with videos related to
Page
of 7
Sort By:
Blood Advances
|
August 19, 2024
Targeting CDC42 reduces skeletal degeneration after hematopoietic stem cell transplantation
Theresa Landspersky, Merle Stein, Mehmet Saçma, et al.
Molecular Cell
|
February 11, 2021
The IMiD target CRBN determines HSP90 activity toward transmembrane proteins essential in multiple myeloma
Michael Heider, Ruth Eichner, Jacob Stroh, et al.
Journal of Translational Medicine
|
June 13, 2024
Correction: Real‑world data suggest effectiveness of the allogeneic mesenchymal stromal cells preparation MSC‑FFM in ruxolitinib‑refractory acute graft‑versus‑host disease
Halvard Bonig, Mareike Verbeek, Peter Herhaus, et al.
Journal of Translational Medicine
|
November 22, 2023
Real-world data suggest effectiveness of the allogeneic mesenchymal stromal cells preparation MSC-FFM in ruxolitinib-refractory acute graft-versus-host disease
Halvard Bonig, Mareike Verbeek, Peter Herhaus, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
September 24, 2018
Outcomes of Haploidentical Transplantation in Patients with Relapsed Multiple Myeloma: An EBMT/CIBMTR Report
Firoozeh Sahebi, Laurent Garderet, Abraham S Kanate, et al.
Bone Marrow Transplantation
|
May 27, 2026
Outcomes of mixed phenotype acute leukemia undergoing allogeneic stem cell transplantation: a retrospective study of the ALWP of EBMT
Annalisa Paviglianiti, Maud Ngoya, Regis Peffault de la Tour, et al.
Bone Marrow Transplantation
|
July 7, 2023
Survival advantage of treosulfan plus fludarabine (FT14) compared to busulfan plus fludarabine (FB4) in active acute myeloid leukemia post allogeneic transplantation: an analysis from the European Society for Blood and Marrow Transplantation (EBMT) Acute Leukemia Working Party (ALWP)
Eleni Gavriilaki, Ioanna Sakellari, Myriam Labopin, et al.
Bone Marrow Transplantation
|
March 13, 2025
Allogeneic hematopoietic cell transplantation after infection with SARS-CoV-2 during the COVID-19 pandemic: a multicenter retrospective analysis
Osama Ahmad, Nicolaus Kröger, Eva Wagner-Drouet, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
September 3, 2018
HLA-Mismatched Donors in Patients with Myelodysplastic Syndrome: An EBMT Registry Analysis
Marie Robin, Raphaël Porcher, Annalisa Ruggeri, et al.
Bone Marrow Transplantation
|
October 15, 2025
Transplant conditioning intensity (TCI) score predicts allo-HCT outcomes in patients with myelofibrosis: a study of the Chronic Malignancies Working Party of EBMT
Patryk Sobieralski, Tomasz Czerw, Luuk Gras, et al.
Page
of 7
Search research articles
Search
Showing results (41-50 of 61) with videos related to
Sort By:
Page
of 7
Blood Advances
|
August 19, 2024
Targeting CDC42 reduces skeletal degeneration after hematopoietic stem cell transplantation
Theresa Landspersky, Merle Stein, Mehmet Saçma, et al.
Molecular Cell
|
February 11, 2021
The IMiD target CRBN determines HSP90 activity toward transmembrane proteins essential in multiple myeloma
Michael Heider, Ruth Eichner, Jacob Stroh, et al.
Journal of Translational Medicine
|
June 13, 2024
Correction: Real‑world data suggest effectiveness of the allogeneic mesenchymal stromal cells preparation MSC‑FFM in ruxolitinib‑refractory acute graft‑versus‑host disease
Halvard Bonig, Mareike Verbeek, Peter Herhaus, et al.
Journal of Translational Medicine
|
November 22, 2023
Real-world data suggest effectiveness of the allogeneic mesenchymal stromal cells preparation MSC-FFM in ruxolitinib-refractory acute graft-versus-host disease
Halvard Bonig, Mareike Verbeek, Peter Herhaus, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
September 24, 2018
Outcomes of Haploidentical Transplantation in Patients with Relapsed Multiple Myeloma: An EBMT/CIBMTR Report
Firoozeh Sahebi, Laurent Garderet, Abraham S Kanate, et al.
Bone Marrow Transplantation
|
May 27, 2026
Outcomes of mixed phenotype acute leukemia undergoing allogeneic stem cell transplantation: a retrospective study of the ALWP of EBMT
Annalisa Paviglianiti, Maud Ngoya, Regis Peffault de la Tour, et al.
Bone Marrow Transplantation
|
July 7, 2023
Survival advantage of treosulfan plus fludarabine (FT14) compared to busulfan plus fludarabine (FB4) in active acute myeloid leukemia post allogeneic transplantation: an analysis from the European Society for Blood and Marrow Transplantation (EBMT) Acute Leukemia Working Party (ALWP)
Eleni Gavriilaki, Ioanna Sakellari, Myriam Labopin, et al.
Bone Marrow Transplantation
|
March 13, 2025
Allogeneic hematopoietic cell transplantation after infection with SARS-CoV-2 during the COVID-19 pandemic: a multicenter retrospective analysis
Osama Ahmad, Nicolaus Kröger, Eva Wagner-Drouet, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
September 3, 2018
HLA-Mismatched Donors in Patients with Myelodysplastic Syndrome: An EBMT Registry Analysis
Marie Robin, Raphaël Porcher, Annalisa Ruggeri, et al.
Bone Marrow Transplantation
|
October 15, 2025
Transplant conditioning intensity (TCI) score predicts allo-HCT outcomes in patients with myelofibrosis: a study of the Chronic Malignancies Working Party of EBMT
Patryk Sobieralski, Tomasz Czerw, Luuk Gras, et al.
Page
of 7